Cite
HARVARD Citation
Mrak, D. et al. (2022). Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Annals of the rheumatic diseases. 81 (12), pp. 1750-1756. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mrak, D. et al. (2022). Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Annals of the rheumatic diseases. 81 (12), pp. 1750-1756. [Online].